资讯
Special CallCompany ParticipantsGuido Oelkers - CEO & PresidentMatthew WinfieldConference Call ParticipantsHerbert S.
The FDA has accepted for review the BLA for nanoencapsulated sirolimus plus pegadricase in the treatment of uncontrolled gout.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果